期刊文献+

麝香保心丸治疗冠心病合并转氨酶升高的疗效观察 被引量:2

Clinical observation on treating coronary heart disease and high level of transaminases with Shexiang Baoxin pill
下载PDF
导出
摘要 目的:探讨麝香保心丸对因肝功能异常,停服他汀类药物的冠心病患者的治疗疗效。方法:连续入选100例冠心病患者,谷丙转氨酶(ALT)均大于120u/L,均停服他汀类药物;随机分两组,各50例,治疗组加用麝香保心丸口服,2丸/次(每丸22.5mg),3次/d,持续6个月的治疗;其余治疗两组相同;观察各组治疗效果。结果:治疗组患者血脂,心电图及临床效果明显优于对照组,有统计学差异(P<0.05)。结论:转氨酶升高的冠心病患者停用他汀类药物给予麝香保心丸治疗效果肯定。 Objective:To observe the effect of Shexiang Baoxin pill to treat coronary heart disease with high level of transaminases.Methods:100 patients with CHD that have stoped taking statins were continually enrolled in this study,whoes cereal third transaminase(ALT)are more than 120u/L;It is randomly divided into two groups,with 50 patients in each group.The treatment group take the Shexiang Baoxin pill,2 pills/time(each pill22.5mg),3 times/d,continuing for at least 6 months.Observe the treatment effect.Results the treatment group patientsblood fat,electrocardiogram and clinical effect is much better than control group,statistically significant(P 0.05).Conclusion;Shexiang Baoxin pill has the function to treating coronary heart disease with high level of transaminases.
作者 袁林
出处 《中医临床研究》 2012年第7期24-25,共2页 Clinical Journal Of Chinese Medicine
关键词 麝香保心丸 冠心病 肝功能异常 Shexiang Baoxin pill Coronary heart disease Abnormal liver function
  • 相关文献

参考文献10

  • 1Sever P S, Poulter N R, Mastorantonakis S, et al. Coronary heart disease benefits from blood pressure and lipid-lowering[J].Int J Cardiol. 2009, 135(2): 218-222.
  • 2Mega S, Nusca A, Patti G. [Percutaneous coronary interventions and statin therapy][J]. Recenti Prog Med. 2012,103(1):5-10.
  • 3Arsenault B J, Boekholdt S M, Hovingh G K, et al. The 719Arg Variant of KIF6 and Cardiovascular Outcomes in Statin-Treated, Stable COronary Patients of the Treating to New Targets and Incremental Decrease in End Points Through Aggressive Lipid-Lowering Prospective Studies[J].Circ Cardiovasc Genet. 2012 5(1):51-57.
  • 4惠丽.步长脑心通治疗冠心病合并高血脂的疗效观察[J].医学新知,2008,18(6):355-356. 被引量:13
  • 5高利霞.步长脑心通胶囊治疗老年人冠心病合并血脂紊乱64例[J].中国中医药现代远程教育,2011,9(3):165-166. 被引量:11
  • 6Tetik S, Ak K, Sahin Y, et al. Postoperative statin therapy attenuates the intensity of systemic inflammation and increases fibrinolysis after coronary artery bypass grafting[J]. Clin Appl Thromb Hemost. 2011,17(5):526-531.
  • 7Nakamura M, Yamashita T, Yajima J, et al. Impact of early statin initiation on secondary prevention in Japanese patients with coronary artery disease[J]. J Cardiol. 2011, 57(2):172-180.
  • 8Kulik A, Shrank W H, Levin R, et al. Adherence to statin therapy in elderly patients after hospitalization for coronary revascularization[J].Am J Cardiol. 2011,107(10):1409-1414.
  • 9路世亮,李霞丽,原冬亚.麝香保心丸治疗冠心病心绞痛100例[J].中国现代药物应用,2010,4(3):130-130. 被引量:3
  • 10黄爱君.麝香保心丸治疗冠心病心绞痛65例[J].中国中医急症,2011,20(5):806-806. 被引量:8

二级参考文献13

  • 1徐成斌.强化调脂有望逆转动脉粥样硬化[J].中华心血管病杂志,2004,32(9):862-864. 被引量:17
  • 2张一凡,袁州,张忠雷.尼莫地平对高血压脑出血患者脑血管动力学指标的影响[J].临床神经病学杂志,2007,20(1):61-63. 被引量:22
  • 3国际心脏病学会和协会及世界卫生组织临床命名标准化联合专题组.缺血性心脏病的命名及诊断标准[J].中华心血管病杂志,1981,9(2):75-75.
  • 4《中华心血管病杂志》编辑委员会.血脂异常预防建议.中华心血管病杂志,2003,6:217-217.
  • 5周仲英,蔡淦.中医内科学[M].2版.北京:人民卫生出版社,2004:179-192.
  • 6赵步长,伍海勤,赵涛.脚心同治[M].北京:人民卫生出版社,2006,10:312-315.
  • 7叶任高.内科学[M]5版[M].北京:人民卫生出版社,2000.961.
  • 8中华人民共和国卫生部.中药新药临床研究指导原则[Z].,1993.32.
  • 9傅祖植.血脂异常和脂蛋白病[M]//叶任高,陆再英.内科学.第6版.北京:人民卫生出版社,2005:821-831.
  • 10常永超,杨旭明,简雪峰,许德英.高脂血症患者的血液流变学改变[J].临床荟萃,2002,17(2):102-103. 被引量:16

共引文献29

同被引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部